BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7541865)

  • 1. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent.
    Aus G; Hugosson J; Norlén L
    J Urol; 1995 Aug; 154(2 Pt 1):466-9. PubMed ID: 7541865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival and mortality in prostate cancer treated with noncurative intent.
    Aus G; Hugosson J; Norlén L
    J Urol; 1995 Aug; 154(2 Pt 1):460-5. PubMed ID: 7541864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-curative treatment of prostate carcinoma. Outcome in Göteborg].
    Aus G; Hugosson J
    Urologe A; 1996 Nov; 35(6):449-53. PubMed ID: 9064881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of prostate cancer from diagnosis until death.
    Otnes B; Harvei S; Fosså SD
    Br J Urol; 1995 Nov; 76(5):587-94. PubMed ID: 8535677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Long-term survival and mortality in prostate cancer treated with noncurative intent.
    Abrahamsson A; Adami HO; Taube A; Kim K; Zelen M; Kulldorff M
    J Urol; 1996 Jan; 155(1):296-8. PubMed ID: 7490872
    [No Abstract]   [Full Text] [Related]  

  • 7. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.
    Crain DS; Amling CL; Kane CJ
    J Urol; 2004 Feb; 171(2 Pt 1):668-71. PubMed ID: 14713783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed therapy of clinically localized prostatic carcinoma. Experiences of the Karolinska Hospital].
    Adolfsson J
    Urologe A; 1996 Nov; 35(6):454-5. PubMed ID: 9064882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.
    Borre M; Nerstrøm B; Overgaard J
    Cancer; 1997 Sep; 80(5):917-28. PubMed ID: 9307192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System.
    Braga SFM; Souza MC; Oliveira RR; Andrade EIG; Acurcio FA; Cherchiglia ML
    Rev Saude Publica; 2017 May; 51(0):46. PubMed ID: 28538811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of hormone refractory prostate cancer: hospital care and palliative care resource use at a VA medical center.
    Hwang SS; Chang VT; Alejandro Y; Mulaparthi S; Cogswell J; Srinivas S; Kasimis B
    Cancer Invest; 2004; 22(6):849-57. PubMed ID: 15641482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the prostate: an expensive way to die.
    Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
    Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative transurethral resection of the prostate: functional outcome and impact on survival.
    Marszalek M; Ponholzer A; Rauchenwald M; Madersbacher S
    BJU Int; 2007 Jan; 99(1):56-9. PubMed ID: 17034496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Ladjevardi S; Sandblom G; Berglund A; Varenhorst E
    Eur Urol; 2010 Apr; 57(4):631-8. PubMed ID: 19299069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup results after expectant management of stage A1 prostatic cancer.
    Zhang G; Wasserman NF; Sidi AA; Reinberg Y; Reddy PK
    J Urol; 1991 Jul; 146(1):99-102; discussion 102-3. PubMed ID: 1711592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients.
    Noordzij MA; Bogdanowicz JF; van Krimpen C; van der Kwast TH; van Steenbrugge GJ
    J Urol; 1997 Nov; 158(5):1880-4; discussion 1884-5. PubMed ID: 9334622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for hospital care of patients with clinically localized prostate cancer managed by noncurative intent: a population based registry study.
    Brasso K; Friis S; Juel K; Jørgensen T; Iversen P
    J Urol; 2000 Apr; 163(4):1150-4. PubMed ID: 10737485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the use of palliative care services by patients with prostate cancer.
    Green JS
    Am J Hosp Palliat Care; 2002; 19(4):259-62. PubMed ID: 12141790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study.
    Lec PM; Lenis AT; Brisbane W; Sharma V; Golla V; Gollapudi K; Blumberg J; Drakaki A; Bergman J; Chamie K
    Urol Oncol; 2020 Nov; 38(11):854.e1-854.e9. PubMed ID: 32430252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.